AI Boosts Science
Curated by the Inblix editorial team
Anthropic has launched Claude Science, an AI workbench for scientists that streamlines tools and datasets, and announced plans to develop its own drugs, focusing on neglected diseases. This move puts Anthropic in a unique position, selling software to competing drugmakers while developing its own treatments. The company’s plans are still unclear, but experts say AI is already being applied at every stage of drug discovery, from research to manufacturing. Why it matters: Anthropic’s move marks a significant shift in the AI landscape, as major companies begin to leverage AI not just as a tool, but as a driver of scientific discovery and innovation.
💡 Key Takeaways
- Anthropic has launched Claude Science, an AI workbench for scientists to accelerate discovery and development
- The company plans to develop its own drugs, focusing on neglected diseases, and will sell software to competing drugmakers
- AI is being applied at every stage of drug discovery, from research to manufacturing, and is expected to dramatically accelerate the pace of scientific progress
Keep reading: See related articles below for more coverage on this topic.
Get smarter about AI
The sharpest AI news, curated daily. Delivered free to your inbox.